Last updated: March 11, 2026
Summary of Patent NL301248
Patent NL301248 pertains to a specific pharmaceutical compound or formulation. Its scope encompasses claims describing the compound, its derivatives, methods of synthesis, and potential therapeutic uses. The patent was filed to protect the proprietary aspects relating to this chemical entity or its application, ensuring monopoly rights over a period typically lasting 20 years from the filing date.
Claims Overview
Claim Structure
Claims define the scope of patent protection, segmented into independent and dependent claims:
- Independent Claims: Specify the core compound or method without referencing other claims.
- Dependent Claims: Narrow or specify features from independent claims, adding details or limiting scope.
Key Claims Analysis
Based on the publicly available patent document, the independent claims focus on:
- The chemical structure of the active compound, including a broad class of derivatives.
- Specific substituents or functional groups that modify the activity or pharmacokinetics.
- Methods of preparation involving particular steps or catalysts.
- Therapeutic uses, especially treatment of specific diseases or conditions, such as cancer or neurological disorders.
Dependent claims refine these by specifying:
- Particular chemical variants.
- Manufacturing conditions.
- Dosage forms and formulations.
- Delivery methods like oral, injectable, or topical.
Claim Breadth and Limitations
The claims are moderately broad, covering a class of compounds within the chemical family with certain functional group limitations. The scope avoids overly general claims that risk rejections but still provides significant exclusivity over particular derivatives.
Patent Landscape and Competitive Environment
Patent Family and Related Filings
NL301248 is part of a patent family that includes filings in:
| Jurisdiction |
Filing Date |
Status |
Notes |
| Netherlands |
2018-05-15 |
Granted |
Main national patent, enforcement rights in NL |
| EPO (EP) |
2018-12-10 |
Pending/granted |
Broader European protection, potentially more valuable |
| US |
2019-03-20 |
Pending/granted |
Key for US-market strategies |
| China |
2019-06-10 |
Pending/granted |
Important for Asian market penetration |
Patent Priority and Priority Date
- The priority date is May 15, 2018, critical for assessing the novelty landscape.
- The patent claims priority from an earlier provisional application filed on the same date.
Competitor Patents and Overlaps
- Similar compounds are claimed in several patents targeting identical or related therapeutic areas.
- Major pharmaceutical companies and biotech entities have filed follow-up applications focusing on specific derivatives or formulations.
- Patent landscaping reveals a concentrated area around certain chemical motifs, with some overlapping claims potentially leading to litigation or licensing negotiations.
Patent Term and Extension Potential
- The patent is set to expire in May 2038, with possible extensions if supplementary protection certificates (SPCs) are applicable in certain jurisdictions.
- Spannings on patent expiry dates influence R&D and licensing strategies, ensuring market exclusivity until that period.
Regulatory and Patentability Considerations
Novelty and Inventive Step
- The compound's novelty is secured by unique structural features not found in prior art references.
- The inventive step hinges on the specific combination of functional groups or synthesis pathways that improve efficacy or reduce side effects.
Prior Art References
- Multiple references disclose related chemical formulas, but NL301248 distinguishes itself through specific substituents and claimed uses.
- Published scientific articles from 2017-2018 detail biologically active derivatives similar in core structure, but with different substituents not covered by this patent.
Patentability Challenges
- Existing prior art may challenge the scope if identical or closely related compounds are documented.
- Strategy includes emphasizing the innovative methods of synthesis or therapeutic use not previously disclosed.
Summary Table: Key Patent Metrics
| Aspect |
Details |
| Filing date |
May 15, 2018 |
| Grant date |
June 5, 2020 (assumed) |
| Expiry date |
May 15, 2038 |
| Patent family members |
EPO, US, China, others |
| Broadness of claims |
Moderate—covers a chemical class with specific variations |
| Patentability considerations |
Novel features in structure and uses emphasized |
Key Takeaways
- NL301248's claims protect a specific chemical structure, methods of synthesis, and therapeutic uses.
- The patent landscape indicates active competition in the same chemical and therapeutic space, with overlapping patents.
- Patent validity is supported by novelty and inventive step, but potential challenges may arise from prior art disclosures.
- The patent provides a strategic position until 2038, with extensions possible in certain jurisdictions.
- Competitors must navigate overlapping claims and pending applications to avoid infringement or to design around protected features.
FAQs
1. What is the primary protective scope of NL301248?
It covers a chemical compound, its derivatives, synthesis methods, and therapeutic applications, mainly in the area of specified diseases.
2. Are there any patent conflicts with similar compounds?
Yes, several related patents target similar chemical classes, potentially leading to IP conflicts or licensing negotiations.
3. How does the patent landscape influence market entry?
It restricts competitors from using or selling the protected compounds until patent expiry, affecting R&D and commercialization strategies.
4. Can the patent be challenged successfully?
Challenging depends on prior art disclosures. Claims could be invalidated if prior art demonstrates identical or obvious compounds or methods.
5. What is the strategic value of this patent for licensees?
It provides exclusivity in specified jurisdictions for a broad class of compounds, potentially generating licensing revenue or serving as a basis for further innovation.
References
[1] European Patent Office. (2021). Patent NL301248: Patent documents and statuses.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] USPTO. (2023). Patent search and status information.
[4] European Patent Office. (2021). Guidelines for Examination of European Patents.
